Auxifos is a brand of Sodium Acid Phosphate which contains elemental phosphorous. Hypophosphatemia is a common complication of kidney transplantation, occurring in up to 93% of patients during the first few months after transplantation. Kidney transplantation (KTx) restores many of the disorders accompanying end –stage renal failure .However, hypercalcemia and hypophosphostemia are both common complications after renal transplant. In cases of hypercalcaemia associated with impaired renal function and hypophosphataemia, the main effect of oral phosphate is to bind calcium in the gut and thus reduce calcium absorption.

Product Active Ingredient(s) Strength Features Dosage Form
AUXIFOS Sodium Acid Phosphate anhydrous 968 mg • Corrects high level of calcium in peoples with overactive parathyroid glands
• Corrects low blood level of phosphorous associated with Vitamin D resistant rickets or osteomalacia
• Corrects the dehydration and sodium depletion
Each tablet provides:
Elemental phosphorous 250 mg
Potassium 61.5 mg
Sodium 234.5 mg
Citric Acid anhydrous 400 mg
  • Hypophosphatemia
  • Hypercalcaemia
  • Phosphate depletion
  • Calcium based kidney stone


Copyright © 2013 - Alniche Life Sciences Pvt. Ltd. | All Rights Reserved

Disclaimer: The information provided herein is not medical advice and is not intended to replace medical advice offered by a health care provider. Please consult your health care provider for advice.